1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. Tris Pharma Acquires Park Therapeutics

M&A Deal Summary

Tris Pharma Acquires Park Therapeutics

On April 29, 2021, Tris Pharma acquired life science company Park Therapeutics

Acquisition Highlights
  • This is Tris Pharma’s 2nd transaction in the Life Science sector.
  • This is Tris Pharma’s 2nd transaction in the United States.
  • This is Tris Pharma’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2021-04-29
Target Park Therapeutics
Sector Life Science
Buyer(s) Tris Pharma
Deal Type Add-on Acquisition

Target

Park Therapeutics

Morristown, New Jersey, United States
Park Therapeutics is a developer of an investigational NCE for the treatment of pain which is Phase III-ready. Park Therapeutics is based in Morristown, New Jersey.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Tris Pharma

Monmouth Junction, New Jersey, United States
Category Company
Founded 2000
Sector Life Science
DESCRIPTION

Tris Pharma, Inc. is a fully integrated pharmaceutical company focused on the development of innovative medicines that address unmet patient needs. Tris Pharma, Inc. was founded in 2000 and is based in Monmouth Junction, New Jersey.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-25 NextWave Pharmaceuticals

Cupertino, California, United States

NextWave Pharmaceuticals is a specialty pharmaceutical company developing extended release OTC and prescription products for children and adults. NextWave Pharmaceuticals was founded in 2005 and is based in Cupertino, California.

Buy -
Mergr

Solution for

Product

Company

Legal